New medicines launched with orphan drug designation
STO-REC-STATMFSFNNT2 National
14
Germany · 2025
New medicines launched with orphan drug designation in Germany totalled 14 in 2025 (VFA).
- Publisher
- VFA
- Authority tier
- T2 National
- Locator
- Medikamente gegen seltene Erkrankungen
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
14 der Medikamente erhielten auf Antrag ihrer Hersteller von der EU den Orphan Drug-Status zuerkannt; er attestiert ihnen, zumindest für einen Teil der Erkrankten den bisherigen Behandlungsmöglichkeiten überlegen zu sein.
Verbatim extraction verified: The figure 14 is directly attested in the quoted passage (Medikamente gegen seltene Erkrankungen).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- VFA. (2025). Neue Medikamente in Deutschland: Innovationsbilanz 2025. Retrieved September 17, 2026, from https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Via StatOrigin, https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT
- MLA
- VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025, https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT.
- Chicago
- VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025. https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT.
- BibTeX
- @misc{vfa2025medicinesmmy3ht, author = {{VFA}}, title = {Neue Medikamente in Deutschland: Innovationsbilanz 2025}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT}, note = {Original source: https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- VFA · homepage ↗
- Authority tier
- Tier 2 · National Official
- Report
- Neue Medikamente in Deutschland: Innovationsbilanz 2025
- Type
- Press release
- Published
- —
- Locator
- Medikamente gegen seltene Erkrankungen
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_MFSFNNEE1TKBS57HHBHWMMY3HT